ARTBIO

Cambridge, USA

Collaborations & Partnerships- R&DCollaborations & Partnerships-LicensingCollaborations & Partnerships-ManufactureOriginator, Research & Development Bronze Listing
C-Score
Developing Profile
Company Details
Address c/o Alexandria LaunchLabs, One Kendall Sq, B200, Suite 001, Cambridge, MA 02139
Country USA
Sectors Collaborations & Partnerships- R&D, Collaborations & Partnerships-Licensing, Collaborations & Partnerships-Manufacture, Originator, Research & Development
Website Visit Website
Company Activities

Radioligand therapy (RLT) has offered a promising new approach for cancer treatment. While beta radioligand therapies are currently more common in clinical practice, alpha radioligand therapies offer potentially significantly better efficacy and safety to patients.

The ARTBIO approach is holistic. It is underpinned by a deep understanding of cancer biology, and the infrastructure needed to effectively design, manufacture, and distribute our therapies.

Sectors
Category/Key Word(s)
Company Contacts

No key contacts have been added to this profile yet.

Claim This Profile

This is the company profile page for ARTBIO on the Pharma Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.